Study of Therapeutic Efficacy, Safety and Pharmacokinetic Interactions Between Artemether-Lumefantrine and Nevirapine-Based Antiretrovirals in HIV-Infected Patients With Uncomplicated Falciparum-Malaria in Muheza, Northeastern Tanzania.

Trial Profile

Study of Therapeutic Efficacy, Safety and Pharmacokinetic Interactions Between Artemether-Lumefantrine and Nevirapine-Based Antiretrovirals in HIV-Infected Patients With Uncomplicated Falciparum-Malaria in Muheza, Northeastern Tanzania.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2013

At a glance

  • Drugs Artemether/lumefantrine (Primary) ; Antiretrovirals; Nevirapine
  • Indications HIV-1 infections; Malaria
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Acronyms InterACT
  • Most Recent Events

    • 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jul 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 15 Jul 2010 Actual initiation date (Jul 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top